ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

Pharmacia Letter Announces Suspension Of Two Trials.

May 11, 2001

An Early Look At How NCI Plans To Spend Its Money In 1980

July 7, 1978

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Study Section Members Likelier to Be Funded

August 1, 1986

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009